Daan Gene Co. Hits Day Low at CNY 6.38 Amid Price Pressure

Daan Gene Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 5.81%. The stock reached an intraday low of CNY 6.38, reflecting a challenging trading environment. Over the past year, Daan Gene has generated a return of 12.05%, which is significantly lower than the China Shanghai Composite's return of 23.12%. The company's performance metrics indicate a concerning trend, with net sales declining at an annual rate of 27.73% and operating profit plummeting by 188.34% over the last five years. Financial indicators reveal that the company is facing difficulties, as evidenced by its operating cash flow, which stands at its lowest point of CNY 341.77 million. Additionally, the return on capital employed (ROCE) is negative at -11.96%, and cash and equivalents are also at a low of CNY 2,590.77 million. Daan Gene's current market position reflects a high dividend yield of 0%, and its debt-to-equity ratio is at -0.14, further emphasizing the financial challenges the company is navigating.